Alexandria® — the world’s largest body of medical evidence for clinical decision support and LLM training.

Read the release
Learn more
Logo
  • Solutions
        • Health Systems
          • Pharmacy
          • Research Informatics
          • Value Based Care / Quality
          • GME
        • Life Sciences
          • Brand Planning
          • Precision Medicine AI/ML
          • HEOR, Medical Affairs & RWE
          • Research & Development
          • Commercial Analytics
  • Technology
        • Content
          • Alexandria®
        • Automation Solutions
          • Atropos Evidence™ Agent
          • ChatRWD®
          • Green Button®
          • Forge®
        • Data
          • GENEVA OS®
          • Atropos Evidence™ Network
          • Data Quality Scoring
  • About
    • About Us
    • Careers
  • Resources
    • Resource Center
    • Publications
    • Customer Stories
    • News & Media
    • Press Releases
    • Blog
  • Contact Us
  • Login
Atropos Health Expands Partnership with Databricks with the Launch of the Atropos Evidence Agent MCP on Databricks Marketplace

Atropos Health Expands Partnership with Databricks with the Launch of the Atropos Evidence Agent MCP on Databricks Marketplace

by Megan Soffer | Jun 11, 2026 | Press Release

Atropos Health and Databricks have expanded their partnership, bringing the Atropos Evidence Agent MCP directly to the Databricks Marketplace. Clinicians, researchers, and life sciences teams can now use AI agents to ask questions and get evidence-backed answers drawn...
Association Between Selective Serotonin Reuptake Inhibitor Use and Outcomes in Metastatic Melanoma Treated With Immune Checkpoint Inhibitors

Association Between Selective Serotonin Reuptake Inhibitor Use and Outcomes in Metastatic Melanoma Treated With Immune Checkpoint Inhibitors

by Hencove | Jun 1, 2026 | Presentations, Publications

A poster titled “Association Between Selective Serotonin Reuptake Inhibitor Use and Outcomes in Metastatic Melanoma Treated With Immune Checkpoint Inhibitors: A Real-World Cohort Study” was presented at the ASCO 2026 Annual Meeting by author Sandeep Kumar...
The Atropos Evidence Agent Will Deliver AI-powered Evidence within Physician Workflow with Deeper Ambient Collaboration with Microsoft

The Atropos Evidence Agent Will Deliver AI-powered Evidence within Physician Workflow with Deeper Ambient Collaboration with Microsoft

by Joy Somogyi | Mar 10, 2026 | Press Release

Atropos Health has launched its collaboration with Microsoft Dragon Copilot, an AI clinical assistant, at Stanford Medicine. This collaboration expands upon the existing relationships between Atropos Health, Stanford and Microsoft. By leveraging patient data captured...
Fierce Healthcare Names Atropos Health a “Fierce 15” Company of 2026

Fierce Healthcare Names Atropos Health a “Fierce 15” Company of 2026

by Julia Rudo | Mar 9, 2026 | Press Release

Fierce Healthcare has named Atropos Health as one of 2026’s “Fierce 15” healthcare companies. The annual special report features the most innovative private healthcare companies looking to change the face of the industry. Read the full release
Atropos Health Named to the 2026 New York Digital Health 100

Atropos Health Named to the 2026 New York Digital Health 100

by Julia Rudo | Feb 3, 2026 | News and Media, Press Release

Atropos Health has been named to the 2026 New York Digital Health 100 (DH100), an annual recognition honoring the most innovative and high-impact digital health startups in the New York region. Published by Digital Health New York (DHNY), the DH100 is released in...
« Older Entries
DiviWP Logo
  • Follow
  • Follow

Solutions

Health Systems

Pharmacy

Research Informatics

Value Based Care / Quality

GME

Life Sciences

Brand Planning

Precision Medicine AI/ML

HEOR, Medical Affairs & RWE

Research & Development

Commercial Analytics

Technology

Content

Alexandria®

Automation Solutions

Atropos Evidence™ Agent

ChatRWD®

Green Button®

Forge®

Data

GENEVA OS®

Atropos Evidence™ Network

Data Quality Scoring

About

  • About Us
  • Careers

Resources

  • Resources Center
  • Publications
  • Customer Stories
  • News & Media
  • Press Releases
  • Blog

Copyright © 2026 Atropos Health. All Rights Reserved | Privacy Policy | Ethics Report | Terms of Service

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}